EMA regular press briefing on COVID-19

Table of contents

Date: 28/05/2021
Location: Virtual meeting

Event summary

The European Medicines Agency (EMA) is holding a press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic. The briefing will also cover the outcome of the extraordinary meeting of EMA’s human medicine committee CHMP on Friday, 28 May 2021, to discuss the paediatric indication for Comirnaty.


  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
  • Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force).
  • Georgy Genov (Head of Pharmacovigilance)

The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).

Virtual briefings for the media will now be organised on a regular basis, initially every two weeks. As a complement to these regular technical briefings, EMA will still organise ad-hoc press conferences as necessary and appropriate.

The press briefing will be held in English. No translations will be provided.

Related content

How useful was this page?

Add your rating
1 rating
1 rating